CClinicalTrials.gg
Status unknownNCT02257034Updated Apr 4, 2017

The Effect of Tai Chi in Treating Fibromyalgia

An interventional study of Taichi and Dance in Fibromyalgia, sponsored by Chengdu PLA General Hospital. Status unknown at 1 site in China. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2017-04-04.

Sponsored by Chengdu PLA General Hospital · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Mar 2017), so the status shown — last known as Enrolling by invitation — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Study summary

To evaluate the effect of Tai chi on Fibromyalgia

02

Conditions studied

03

In context

Fibromyalgia

1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.

This study's planned enrollment of 120 is above the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.

Browse Fibromyalgia studies →

Lead sponsor

Chengdu PLA General Hospital is the lead sponsor of 12 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 40 years of age or older
  • meeting the classification of FM per the 1990 ACR criteria
  • approval by a healthcare provider for participation

Exclusion criteria

Exclusion Criteria:

  • had practiced Tai chi within the past 6 months
  • had exercised >30 min three times weekly for past 3 months
  • could not independently ambulate without assistive devices
  • had BPI pain severity or interference scores less than 5
  • had planned elective surgery during study period
  • were actively involved in health-related litigation
  • were unwilling to keep all treatments/medications steady throughout the study period
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Taichi

    patients exercise with Tai chi

    Other: Taichi

  • Sham comparator
    Control

    patients under exercise of dance

    Other: Dance

Interventions

  • OtherTaichi
  • OtherDance
06

What researchers measure

Primary outcomes

  1. Fibromyalgia Impact Questionnaire (FIQ)

    Time frame: up to 48 weeks

07

Study locations

1 site
  • General Hospital of Chengdu Military Area Command PLA
    Chengdu, Sichuan 610083, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02257034
Lead sponsor
Chengdu PLA General Hospital
Responsible party
Yang Min (Ph.D, Chengdu PLA General Hospital) — Principal investigator
First posted
Oct 6, 2014
Start date
Aug 2014
Primary completion
Dec 2022 (estimated)
Completion
Dec 2022 (estimated)
Last update
Apr 4, 2017

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion